Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 7Prostatic Neoplasms 4Precancerous Conditions 2Neoplasms 2Weight Loss 1Uterine Cervical Neoplasms 1Radiation Injuries 1Psoriasis 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Pelvic Inflammatory Disease 1Pain 1Ovarian Neoplasms 1Osteoarthritis 1Fatigue 1Esophageal Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthralgia 1

Interventions

Metformin 52Inositol 21Clomiphene 17Letrozole 16Exercise 14High-Intensity Interval Training 10Folic Acid 10Caloric Restriction 10Progesterone 8Ethinyl Estradiol 8Estradiol 7Diet 6drospirenone 5drospirenone and ethinyl estradiol combination 4Tablets 4In Vitro Oocyte Maturation Techniques 4Estrogens 4Diet, Mediterranean 4Cyproterone Acetate 4Control Groups 4Berberine 4Acupuncture Therapy 4Vitamin D 3Triptorelin Pamoate 3Thioctic Acid 3Spironolactone 3Resistance Training 3Pioglitazone 3Medroxyprogesterone Acetate 3Flutamide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Polycystic Ovary Syndrome × Fatty Acids, Omega-3 × Clear all
NCT07036952 2025-07-24

Effect of Omega-3 Supplementation as Add on Therapy on Metabolic Syndrome in Women With Polycystic Ovary Syndrome.

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Phase NA Enrolling by invitation
68 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡